References
- Glenner G G. Amyloid Deposits and Amyloidosis: The B-Fibrilloses. N Engl J Med 1980; 302: 1283–1292; 1333–1343
- Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem 1962; 10: 355
- Sack G H, Dumars K W, Gummerson K S, Law A, McKusick V A. Three forms of dominant amyloid neuropathy. Johns Hopkins Med J 1981; 149: 239
- Benson M D. Amy loidosis. The Metabolic and Molecular Bases of Inherited Disease, Seventh Edition, C R Sriver, A L Beaudet, W S Sly, D Valle. McGraw Hill Book Co., New York, NY 1995; Volume III: 4159–4191, Chapter 139, Part 18 Connective Tissues
- Andrade C. A peculiar form of peripheral neuropathy. Familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952; 75: 408–427
- Wallace M R, Naylor S L, Kluve-Beckerman B, Long G L, McDonald L, Shows T B, Benson M D. Localization of the human prealbumin gene to chromosome 18. Biochem Biophys Res Commun 1985; 129: 753–758
- Benson M D, Uemichi T. Transthyretin amyloidosis. Amyloid: Int J Exp Clin Invest 1996; 3: 44–58
- Skinner M, Lewis W D, Jones L A, Kasirsky J, Kane K, Ju S T, Jenkins R, Falk R H, Simms R W, Cohen A S. Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med 1994; 120: 133–134
- Costa R H, Lai E, Darnell J E. Transcriptional control of the mouse prealbumin (transthyretin) gene: Both promoter sequences and a distinct enhancer are cell specific. Mol Cell Biol 1986; 6: 4697–4708
- Oatley S J, Blaney J M, Langridge R, Kollman P A. Molecular mechanical studies of hormone-protein interactions: The interaction of T4 and T3 with prealbumin. Biopolymers 1984; 23: 2931
- Monaco H L, Rizzi M, Coda A. Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. Science 1995; 268: 1039–1041
- Blake C CF, Geisow M F, Oatley S J, Rerat B, Rerat C. Structure of prealbumin: Secondary, tertiary and quaternary interactions determined by Fourier refinement at 1 8A. J Mol Biol 1978; 121: 339–356
- Hamilton J A, Steinrauf L K, Braden B C, Liepnieks J J, Benson M D, Holmgren G, Sandgren O, Steen L. The X-ray crystal structure refinements of normal transthyretin and the amyloidogenic Val30 Met variant to 1.7Å resolution. J Biol Chem 1993; 268: 2416–2424
- Hamilton J A, Steinrauf L K, Braden B C, Murrell J R, Benson M D. Structural changes in transthyretin produced by the Ile84Ser mutation which result in decreased affinity for retinol-binding protein. Amyloid: Int J Exp Clin Invest 1996; 3: 1–12
- Damas A M, Ribeiro S, Lamzin V S, Palha J A, Saraiva M J. Structure of Val122Ile variant transthyretin - a cardiomyopathic mutant. Acta Cryst 1996; D52: 966–972
- Steinrauf L K, Hamilton J A, Braden B C, Murrell J R, Benson M D. X-ray crystal structure of the Ala109 Thr variant of human transthyretin which produces euthyroid hyperthyroxinemia. J Biol Chem 1993; 268: 2425–2430
- Wojtczak A, Luft J, Cody V. Structural Aspects of Inotropic Bipyridine Binding. J Biol Chem 1993; 268: 6202–6206
- Wojtczak A, Cody V, Luft J R, Pangborn W. Structures of Human Transthyretin Complexed with Thyroxine at 2.0Å Resolution and 3′,5′-Dinitro-N-acetyl-L-thyronine at 2.2A resolution. Acta Cryst 1996; D52: 758–765
- Damas A M, Sebastião M P, Costa P P, Saraiva M J. A Fiber Diffraction Study of FAP Fibrils. Amyloid and Amyloidosis, R Kisilevsky, M D Benson, B Frangione, J Gauldie, T J Muckle, I D Young. Parthenon Publishing, New York and London 1994; 492–494, (1993)
- Blake C CF, Serpell L. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continous ß-sheet helix. Structure 1996; 4: 989–998
- Serpell L C, Sunde M, Fraser P E, Luther P K, Morris E P, Sandgren O, Lundgren E, Blake C CF. Examination of the Structure of the Transthyretin Amyloid Fibril by Image Reconstruction from Electron Micrographs. J Mol Biol 1995; 254: 113–118
- Jarvis J A, Munro S LA, Craik D J. Structural Analysis of Peptide Fragment 71–93 of Transthyretin by NMR Spectroscopy and Electron Microscopy: Insight into Amyloid Fibril Formation. Biochemistty 1994; 33: 33–41
- Terry C J, Damas A M, Oliveira P, Saraiva M JM, Alves I L, Costa P P, Matias P M, Sakaki Y, Blake C CF. Structure of Met30 variant of transthyretin and its amyloidogenic implications. EM5O J 1993; 12: 735–741
- Kelly J W, Lansbury P T, Jr. A chemical approach to elucidate the mechanism of transthyretin and β-protein amyloid fibril formation. Amyloid: Int J Exp Clin Invest 1994; 1: 186–205
- Serpell L C, Goldsteins G, Dacklin I, Lundgren E, Blake C CF. The “edge strand-hypothesis: prediction and test of a mutational “hot-spot” on the transthyretin molecule associated with FAP amyloidogenesis. Amyloid: Int J Exp Clin Invest 1996; 3: 75–85
- Murrell J R, Schoner R G, Liepnieks J J, Rosen H N, Moses A C, Benson M D. Production and functional analysis of normal and variant recombinant human transthyretin proteins. J Biol Chem 1992; 267: 16595–16600
- Bailey S. Collaborative Computational Project, Number 4. The CCP4 Suite: Programs for protein crystallography. Acta Cryst 1994; D50: 760–763
- Matthews B W. Solvent content of protein crystals. J Mol Biol 1968; 33: 491–497
- Sato M, Yamamoto M, Imada K, Katsube Y, Tanaka N, Higashi T. A high-speed data-collection system for large-unit cell crystals using an imaging plate as a detector. J Appl Cyst 1992; 25: 348–357
- Chen D, Ferrara J D, Higashi T, Jacobson R A, Klein C LD, Swepston P N, Vincent B R, Xiong L. ‘BIOTEX Ver. 1.0’, Program Suite. Molecular Structure Corporation, Houston 1993–1996
- Brünger A T, Kuriyan J, Karplus M. Crystallographic R factor refinement by molecular dynamics. Science 1987; 235: 458–460
- Jones T A, Zou J Y, Cowan S W, Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Cryst 1991; A47: 110–119
- Brunger A T. Simulated Annealing in Crystallography. Annu Rev Phys Chem 1991; 42: 197–223
- Molecular Simulations Inc. ‘QUANTA96’. Program Suite, San Diego, CA 1996
- Brunger A T. The Free R Value: a Novel Statistical Quantity for Assessing the Accuracy of Crystal Structures. Nature 1992; 355: 472–474
- Luzzati V. Traitement Statistique des Erreurs dans la Determination des Structures Cristallines. Acta Cryst 1952; 5: 142–152
- Read R J. Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Cryst 1986; A42: 140–149
- Hubbard S J, Thornton J M. ‘ACCESS’. Computer Program. Department of Biochemistry and Molecular Biology, University College London. 1993
- Lee B, Richards F M. The interpretation of protein structures: estimation of static accessibility. J Mol Biol 1971; 55: 379–400
- MacLaskowski R A., Arthur M W, Moss D S, Thornton J M. PROCHECK: a program to check the stereochemi-cal quality of protein structures. J Appl Cryst 1993; 26: 283–291
- Kabsch W. A Solution for the Best Rotation to Relate Two Sets of Vectors. Acta Cryst 1978; A32: 922–923
- Colon W, Kelly J W. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 1992; 31: 8654–8660
- Lai Colon Z. W, Kelly J W. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 1996; 35: 6470–6482
- Thylen C, Wahlqvist J, Haettner E., Sandgren O, Holmgren G, Lundgren E. Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation. EMBO J 1993; 12: 743–748
- Goldsteins G, Anderson K, Olofsson A, Dacklin I., Edvinsson A, Baranov V, Sandgren O, Thylen C, Hammarstrom S, Lundgren E. Characterization of Two Highly Amyloidogenic Mutants of Transthyretin. Biochemistry 1997; 36: 5346–5352
- Gustavsson A., Engstroem U, Westermark P. Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro. Biochem Biophys Res Comm 1991; 175: 1159–1164
- Dwulet F E, Benson M D. Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss). J Clin Invest 1986; 78: 880–886
- Wallace M R, Dwulet F E, Conneally P M, Benson M D. Biochemical and molecular genetic characteristic of a new variant prealbumin associated with hereditary amyloidosis. J Clin Invest 1986; 78: 6–12
- Schormann N, Murrell J R, Liepnieks J J, Benson M D. Tertiary structure of an amyloid immunoglobulin light chain protein: A proposed model for amyloid fibril formation. Proc Natl Acad Sci USA 1995; 92: 9490–9494
- Wetzel R. Mutations and off-pathway aggregation of proteins. Trends Biotech 1994; 12: 193–198
- Kraulis P. MOLSCRIPT: a Program to Produce Both Detailed and Schematic Plot of Protein Structures. J Appl Cryst 1991; 24: 946–950
- Kabsch W, Sander C. Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983; 22: 2577–2637
- Sayle R. ‘RASMOL Ver. 2.6’. Molecular Graphics Program, GlaxoUK 1995